Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Cash & Equivalents (2021 - 2026)

Aveanna Healthcare Holdings' Cash & Equivalents history spans 6 years, with the latest figure at $193.3 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 129.29% year-over-year to $193.3 million; the TTM value through Jan 2026 reached $193.3 million, up 129.29%, while the annual FY2026 figure was $193.3 million, 129.29% up from the prior year.
  • Cash & Equivalents reached $193.3 million in Q1 2026 per AVAH's latest filing, up from $145.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $193.3 million in Q1 2026 to a low of $17.4 million in Q2 2022.
  • Average Cash & Equivalents over 5 years is $62.8 million, with a median of $47.7 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: crashed 83.61% in 2022, then surged 129.29% in 2026.
  • A 5-year view of Cash & Equivalents shows it stood at $19.2 million in 2022, then surged by 128.66% to $43.9 million in 2023, then surged by 91.82% to $84.3 million in 2024, then soared by 73.06% to $145.9 million in 2025, then surged by 32.49% to $193.3 million in 2026.
  • Per Business Quant, the three most recent readings for AVAH's Cash & Equivalents are $193.3 million (Q1 2026), $145.9 million (Q3 2025), and $100.7 million (Q2 2025).